REMASTer: REcurrent Brain Metastases After SRS Trial
Status:
Not yet recruiting
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
Randomized, post-market multi-center study investigating the efficacy of two sets of
treatment algorithms in brain metastases (BM) patients at the time of radiographic
progression evidence after stereotactic radiosurgery (SRS), with or without resection.